Morey T, Benatar T, Xu S, Wang L, Ip P, Nitya-Nootan T
Sci Rep. 2025; 15(1):6769.
PMID: 40000726
PMC: 11861912.
DOI: 10.1038/s41598-025-87944-2.
Wilhelm K, Vissa A, Groves J
Proc Natl Acad Sci U S A. 2024; 121(39):e2406680121.
PMID: 39298491
PMC: 11441509.
DOI: 10.1073/pnas.2406680121.
Patel A, Kutuzov M, Dustin M, Anton van der Merwe P, Dushek O
Immunother Adv. 2024; 4(1):ltae004.
PMID: 38978751
PMC: 11228853.
DOI: 10.1093/immadv/ltae004.
Wilhelm K, Vissa A, Groves J
bioRxiv. 2024; .
PMID: 38617215
PMC: 11014569.
DOI: 10.1101/2024.04.01.587588.
Wither M, White W, Pendyala S, Leanza P, Fowler D, Kueh H
Proc Natl Acad Sci U S A. 2023; 120(52):e2308366120.
PMID: 38113261
PMC: 10756264.
DOI: 10.1073/pnas.2308366120.
Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion.
Sun Y, Florio T, Gupta S, Young M, Marshall Q, Garfinkle S
Sci Immunol. 2023; 8(90):eadj5792.
PMID: 38039376
PMC: 10782944.
DOI: 10.1126/sciimmunol.adj5792.
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.
Gaud G, Achar S, Bourassa F, Davies J, Hatzihristidis T, Choi S
Nat Immunol. 2023; 24(12):2121-2134.
PMID: 37945821
PMC: 11482260.
DOI: 10.1038/s41590-023-01663-2.
Tuning the potency and selectivity of ImmTAC molecules by affinity modulation.
Robertson I, Mulvaney R, Dieckmann N, Vantellini A, Canestraro M, Amicarella F
Clin Exp Immunol. 2023; 215(2):105-119.
PMID: 37930865
PMC: 10847821.
DOI: 10.1093/cei/uxad120.
Proofreading does not result in more reliable ligand discrimination in receptor signaling due to its inherent stochasticity.
Kirby D, Zilman A
Proc Natl Acad Sci U S A. 2023; 120(21):e2212795120.
PMID: 37192165
PMC: 10214210.
DOI: 10.1073/pnas.2212795120.
Inefficient exploitation of accessory receptors reduces the sensitivity of chimeric antigen receptors.
Burton J, Siller-Farfan J, Pettmann J, Salzer B, Kutuzov M, Anton van der Merwe P
Proc Natl Acad Sci U S A. 2023; 120(2):e2216352120.
PMID: 36598945
PMC: 9926289.
DOI: 10.1073/pnas.2216352120.
The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering.
Shevyrev D, Tereshchenko V, Sennikov S
Int J Mol Sci. 2022; 23(23).
PMID: 36499057
PMC: 9740949.
DOI: 10.3390/ijms232314728.
Kinetic proofreading through the multi-step activation of the ZAP70 kinase underlies early T cell ligand discrimination.
Voisinne G, Locard-Paulet M, Froment C, Maturin E, Menoita M, Girard L
Nat Immunol. 2022; 23(9):1355-1364.
PMID: 36045187
PMC: 9477740.
DOI: 10.1038/s41590-022-01288-x.
CD8 T cell function and cross-reactivity explored by stepwise increased peptide-HLA versus TCR affinity.
Baumgaertner P, Schmidt J, Costa-Nunes C, Bordry N, Guillaume P, Luescher I
Front Immunol. 2022; 13:973986.
PMID: 36032094
PMC: 9399405.
DOI: 10.3389/fimmu.2022.973986.
Covalent TCR-peptide-MHC interactions induce T cell activation and redirect T cell fate in the thymus.
Szeto C, Zareie P, Wirasinha R, Zhang J, Nguyen A, Riboldi-Tunnicliffe A
Nat Commun. 2022; 13(1):4951.
PMID: 35999236
PMC: 9399087.
DOI: 10.1038/s41467-022-32692-4.
Cellular kinetics: A clinical and computational review of CAR-T cell pharmacology.
Qi T, McGrath K, Ranganathan R, Dotti G, Cao Y
Adv Drug Deliv Rev. 2022; 188:114421.
PMID: 35809868
PMC: 9520251.
DOI: 10.1016/j.addr.2022.114421.
T Cell Recognition of Tumor Neoantigens and Insights Into T Cell Immunotherapy.
Sim M, Sun P
Front Immunol. 2022; 13:833017.
PMID: 35222422
PMC: 8867076.
DOI: 10.3389/fimmu.2022.833017.
Fluctuations in T cell receptor and pMHC interactions regulate T cell activation.
Egan J, Abu-Shah E, Dushek O, Elliott T, MacArthur B
J R Soc Interface. 2022; 19(187):20210589.
PMID: 35135295
PMC: 8833104.
DOI: 10.1098/rsif.2021.0589.
Perfect adaptation of CD8 T cell responses to constant antigen input over a wide range of affinities is overcome by costimulation.
Trendel N, Kruger P, Gaglione S, Nguyen J, Pettmann J, Sontag E
Sci Signal. 2021; 14(666):eaay9363.
PMID: 34855472
PMC: 7615691.
DOI: 10.1126/scisignal.aay9363.
Quantitative contributions of TNF receptor superfamily members to CD8 T-cell responses.
Nguyen J, Pettmann J, Kruger P, Dushek O
Mol Syst Biol. 2021; 17(11):e10560.
PMID: 34806839
PMC: 8607805.
DOI: 10.15252/msb.202110560.
Predicting T Cell Receptor Antigen Specificity From Structural Features Derived From Homology Models of Receptor-Peptide-Major Histocompatibility Complexes.
Milighetti M, Shawe-Taylor J, Chain B
Front Physiol. 2021; 12:730908.
PMID: 34566692
PMC: 8456106.
DOI: 10.3389/fphys.2021.730908.